Andrew Khouri

Andrew Khouri brings over 15 years of experience in strategy and finance across the life sciences industry. Before joining Reaction Biology, he was with Rapid Micro Biosystems, where he was responsible for corporate strategy and led multiple private and public financings. Prior to Rapid Micro, he was Vice President at Quaker Partners, a healthcare investment firm, where he focused on investments across the spectrum of the healthcare industry, including biopharmaceuticals, medtech, life science tools, and digital health companies. He began his career as a strategy consultant with Leerink Swann, advising global pharmaceutical companies on strategy development, commercial planning, and organizational restructurings.

Andrew holds a BA in Biology from Harvard University.